Материалов:
1 081 645

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 265100

Страница 1 из 26510

The complement inhibitors in COVID-19: Future expectations
Korotchaeva Y., Kozlovskaya N., Bobrova L., Kamyshova E., Demyanova K., Moiseev S.
The complement inhibitors in COVID-19: Future expectations
The complement inhibitors in COVID-19: Future expectations
Korotchaeva Y.
The complement inhibitors in COVID-19: Future expectations
Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD)
Simaniv, T.O., Bakhtiyarova, K.Z., Belova, A.N., Goncharova, Z.A., Sivertseva, S.A., Spirin, N.N., Totolyan, N.A., Trushnikova, T.N., Turova, E.L., Khaibullin, T.I., Sherman, M.A., Симанив, Т.О., Бахтиярова, К.З., Белова, А.Н., Гончарова, З.А., Сиверцева, С.А., Спирин, Н.Н., Тотолян, Н.А., Трушникова, Т.Н., Турова, Е.Л., Хайбуллин, Т.И., Шерман, М.А., Бойко, А.Н.
ингибиторы С5-компонента комплемента, опыт применения которых пока ограничен, однако опубликованные данные
DYNAMICS OF ACTIVITY OF SOME COMPONENTS OF COMPLEMENT IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN
С. С. Андина, S. S. Andina, А. М. Бичучер, A. M. Bichucher, Н. В. Гора, N. V. Gora, Л. В. Козлов, L. V. Kozlov, О. В. Логунов, O. V. Logunov, О. А. Башкина, O. A. Bashkina, О. В. Рубальский, O. V. Rubalsky, В. А. Алешкин, A. V. Aleshkin
DYNAMICS OF ACTIVITY OF SOME COMPONENTS OF COMPLEMENT IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN
Blockade of Metabotropic GABA-B Receptors as an Approach to Reduce Toxic Peripheral Effects of Cholinesterase Inhibitors
Lenina O., Masson P., Petrov K.
can complement the current therapy of acute poisoning by cholinesterase inhibitors.
Dual complements for domains of C n
Aizenberg L., Liflyand E., Nekvinda A.
Let Ω ⊂ C n be a bounded, strictly convex domain and Ω ∼ be its dual complement. Very few
Eculizumab in treatment of ANCA-associated vasculitis complicated with Covid-19 Clinical observations
Frolova Nadiya F.
, which activates an alternative complement cascade with cleavage of C5 into C5a and C5b. Anaphylatoxin C5
Eculizumab for pregnancy-related atypical hemolytic uremic syndrome
Korotchaeva Y., Kozlovskaya N., Shifman E., Kudlay D., Moiseev S.
complement inhibitor
ONTOGENETIC FEATURES OF REACTION OF C3 COMPLEMENT IN RESPONSE TO ACUTE SOMATIC PAIN IN RATS
Bykov I.M., Alekseev V.V., Sepiashvili R.I.
on the immune system, in particular on the C3 complement component, have not been found in the available
Effect of red seaweed sulfated galactans on initial steps of complement activation in vitro
Sokolova E.V.
mattered in ameliorating C5 cleavage by plasmin in extrinsic protease complement activation, but λ

Страница 1 из 26510

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core